| Literature DB >> 33113310 |
Mustafa Akbulut1, Adnan Ak1, Ozgur Arslan1, Arzu Antal Dönmez1, Serpil Taş1, Davut Cekmecelioglu1, Mesut Sismanoglu1, Mehmet Altug Tuncer1.
Abstract
INTRODUCTION: The aim of this study is to compare postoperative outcomes and follow-up of two different modifications facilitating surgical technique of frozen elephant trunk (FET) procedure for complex thoracic aortic diseases - zone 0 (fixation with total arch debranching) and zone 3 (fixation with islet-shape arch repair).Entities:
Keywords: Aneurysm, Dissecting; Aorta; Aortic Diseases; Blood Vessel Prosthesis Implantation; Follow-Up Studies; Hospital Mortality; Spinal Cord Ischemia; Survival Rate
Year: 2020 PMID: 33113310 PMCID: PMC7731864 DOI: 10.21470/1678-9741-2019-0398
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Patients’ characteristics.
| Overall, n (%) | Group A, n (%) | Group B, n (%) | ||
|---|---|---|---|---|
| Age, years (mean±SD) | 54.7±11.4 | 54.3±9.35 | 55.1±12.70 | 0.68 |
| Male | 111 (79.9) | 46 (79.3) | 65 (80.2) | 0.89 |
| Emergency < 24h | 72 (51.8) | 29 (50) | 43 (53.1) | 0.72 |
| CAD | 25 (18) | 13 (22.4) | 12 (14.8) | 0.25 |
| EF < %50 | 15 (10.8) | 6 (10.3) | 9 (11.1) | 0.88 |
| Valve disease | ||||
| Aortic | 18 (12.9) | 8 (13.8) | 10 (12.3) | 0.8 |
| Mitral | 7 (5) | 2 (3.4) | 5 (6.2) | 0.69 |
| Previous cardiac surgery | 27 (19.4) | 17 (29.3) | 10 (12.3) | 0.012 |
| Hypertension | 124 (89.2) | 51 (87.9) | 73 (90.1) | 0.68 |
| COPD | 24 (17.3) | 8 (13.8) | 16 (19.8) | 0.35 |
| Diabetes mellitus | 13 (9.4) | 5 (8.6) | 8 (9.9) | 0.8 |
| Creatinine > 2 mg/dl | 12 (8.6) | 2 (3.4) | 10 (12.3) | 0.07 |
| History of stroke | 5 (3.6) | 2 (3.4) | 3 (3.7) | 1 |
| Marfan disease | 6 (4.3) | 3 (5.2) | 3 (3.7) | 0,69 |
| Family history | 10 (7.2) | 1 (1.7) | 9 (11.1) | 0.04 |
| Complex thoracic aortic diseases | ||||
| ATAAD | 61 (43.9) | 28 (48.3) | 33 (40.7) | 0.377 |
| CTAAD | 26 (18.7) | 17 (29.3) | 9 (11.1) | 0.07 |
| ATBAD | 10 (7.2) | 1 (1.7) | 9 (11.1) | 0.045 |
| CTBAD | 19 (13.7) | 3 (5.2) | 16 (19.8) | 0.022 |
| TAA | 23 (16.5) | 9 (15.5) | 14 (17.3) | 0.782 |
Statistically significant
ATAAD=acute type A aortic dissection; ATBAD=acute type B aortic dissection; CAD=coronary artery diseases; COPD=chronic obstructive pulmonary diseases; CTAAD=chronic type A aortic dissection; CTBAD=chronic type B aortic dissection; EF=ejection fraction; SD=standard deviation; TAA=thoracic aortic aneurysms
Fig. 1Preoperative (A) and postoperative (B) computerized tomography angiography images of frozen elephant trunk modification; zone 0, fixation with total arch de-branching.
Fig. 2Preoperative (A) and postoperative (B) computerized tomography angiography images of frozen elephant trunk modification; zone 3, fixation with islet-shape arch repair.
Perioperative values.
| Overall (mean±SD) | Group A (mean±SD) | Group B (mean±SD) | ||
|---|---|---|---|---|
| Nasopharyngeal temperature (˚C) | 25.8±16.3 | 25.9±1.4 | 25.7±1.7 | 0.32 |
| Total perfusion time (min) | 194.5±66.5 | 225±82 | 172.7±40.9 | < 0.01 |
| ASCP time (min) | 75.6±34.4 | 78.7±46.4 | 73.4±22.4 | 0.47 |
| Visceral ischemia time (min) | 68.6±26.9 | 63.9±31.2 | 71.9±23.1 | 0.03 |
| LSA coverage | 7(5) | 3(5.2) | 4(4.9) | 0.62 |
| Additional operation | ||||
| MR | 4 (2.9) | 0 | 4 (4.9) | 0.14 |
| Bentall | 12 (8.6) | 6 (10.3) | 6 (7.4) | 0.377 |
| AVR | 2 (1.4) | 2 (3.4) | 2 (2.5) | 1 |
| CABG | 8 (5.8) | 5 (8.6) | 3 (3.7) | 0.278 |
| MVR | 4 (2.9) | 2 (3.4) | 0 | 0.172 |
Statistically significant
ASCP=antegrade selective cerebral perfusion; AVR=aortic valve replacement; CABG=coronary artery bypass grafting; LSA=left subclavian artery; MR=mitral reconstruction; MVR=mitral valve replacement; SD=standard deviation
Postoperative outcomes.
| Overall, n (%) | Group A, n (%) | Group B, n (%) | ||
|---|---|---|---|---|
| In-hospital mortality | 20 (14.4) | 8 (13.8) | 12 (14.8) | 0,534 |
| Total mortality | 24 (17.3) | 10 (17.2) | 14 (17.3) | 0.59 |
| Re-intervention | 14 (10.1) | 4 (6.9) | 10 (12.3) | 0,22 |
| Pulmonary complication | 25 (18) | 13 (22.4) | 12 (14.8) | 0,25 |
| Dialysis (temporary/permanent) | 18/2 (12.9/1.4) | 7/1(12.1/1.7) | 11/1 (13.6/1.2) | 1/0.66 |
| Stroke | 7 (5) | 4 (6.9) | 3 (3.7) | 0,32 |
| Spinal cord ischemia | 5 (3.6) | 2 (3.4) | 3 (3.7) | 0.334 |
| ICU stay (days), median (min-max) | 5 (1-45) | 5 (1-45) | 3 (1-36) | 0.3 |
| Hospital stay (days), median (min-max) | 13 (5-61) | 12 (6-61) | 11 (5-46) | 0.56 |
| Bleeding | ||||
| 24 h | 800 (100-5500) | 700 (250-4000) | 600 (100-5500) | 0.75 |
| Total | 1400 (300-6000) | 1100 (300-6000) | 950 (300-5750) | 0.7 |
| Re-sternotomy (bleeding/tamponade) | 16 (11.5) | 7 (12.1) | 9 (11.1) | 0.86 |
ICU=intensive care unit
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| ANOVA | = Analysis of variance | CTBAD | = Chronic type B aortic dissection | |
| ASCP | = Antegrade selective cerebral perfusion | EF | = Ejection fraction | |
| ATAAD | = Acute type A aortic dissection | FET | = Frozen elephant trunk | |
| ATBAD | = Acute type B aortic dissection | ICU | = Intensive care unit | |
| AVR | = Aortic valve replacement | LSA | = Left subclavian artery | |
| CABG | = Coronary artery bypass grafting | MR | = Mitral reconstruction | |
| CAD | = Coronary artery diseases | MVR | = Mitral valve replacement | |
| COPD | = Chronic obstructive pulmonary diseases | SCI | = Spinal cord ischemia | |
| CPB | = Cardiopulmonary bypass | SD | = Standard deviation | |
| CT-A | = Computerized tomography angiography | TAA | = Thoracic aortic aneurysms | |
| CTAAD | = Chronic type A aortic dissection | TEVAR | = Thoracic endovascular repair | |
| Authors' roles & responsibilities | |
|---|---|
| MA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| AA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| OA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| AAD | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| ST | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published |
| DC | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| MS | Drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| MAT | Drafting the work or revising it critically for important intellectual content; final approval of the version to be published |